NTHI — NEONC TECHNOLOGIES HOLDINGS, INC.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1979414 ·
Last close
$4.33
Market Cap
$124.92M
52W High
$11.38
52W Low
$2.50
ADV30
173,998
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — -5,739,306 -4,440,209 9,304,284 6,166,342 22,476,599
Jun 2026 0 — -13,587,109 -14,240,044 5,231,792 1,973,420 23,761,103
Mar 2026 0 — -7,008,539 -8,819,932 3,330,161 138,601 16,561,326
Dec 2025 0 — -13,625,675 -15,524,104 2,823,634 58,729 20,331,363

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-21,156,677
Investing CF
—
Financing CF
$23,505,056
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.71
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-135,814,631
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-43,836,111
Pretax Income TTM
$-47,200,000
Interest Exp TTM
$3,363,889
Analysts
4

Yahoo Snapshot (yfinance, live)

Total Revenue
$39,990
EBITDA
—
Free Cash Flow
$5,401,299
Enterprise Value
$81,030,632
Total Cash
$1,973,420
Total Debt
$328,217
Shares Out
28,850,588
Trailing EPS
$-1.95
Book Value
$-0.81
ROE
—
ROA
-635.0%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 39,990 -58,169,198 -62,146,210 2,823,634 20,331,363 -17,507,729 -20,363,948
Dec 2024 83,000 -7,142,522 -11,898,464 3,417,241 8,922,202 -5,504,961 -4,213,916
Dec 2023 70,462 -8,097,669 -14,921,065 1,265,376 15,253,629 -13,988,253 -1,880,012
Dec 2022 20,000 -2,837,604 -3,046,757 728,682 2,304,093 -1,575,411 -881,736

TTM Snapshot

Revenues TTM
$0
NetIncome TTM
$-41,524,029
OpCashFlow TTM
—
Assets (Latest)
$5,231,792
Forward EPS
$-1.09

Peers — same industry

TickerNameMarket CapLastDaily %
MGNX MACROGENICS INC $131.01M $2.05 —
MSLE Satellos Bioscience Inc. $131.54M $6.20 —
MENS Jyong Biotech Ltd. $133.62M $1.80 —
SPRB SPRUCE BIOSCIENCES, INC. $116.37M $40.49 —
UPB Upstream Bio, Inc. $115.10M $2.10 —

News headlines (Yahoo Finance, 1h cache)

NeOnc Reports Additional Partial Response in Phase 2a Study of Intranasal NEO100
2026-11-17 13:00 · Yahoo
NeOnc CEO Amir Heshmatpour’s 2026 Open-Market Share Purchases Exceed $1.5 Million
2026-11-16 13:00 · Yahoo
NeOnc Technologies Granted FDA Type B End-of-Phase Meeting to Discuss Potential Accelerated Approval Pathway and Phase 3 Confirmatory Trial for Intranasal NEO100
2026-11-11 13:00 · Yahoo
NeOnc CEO Amir Heshmatpour Adds 80,000 Shares in Open-Market Purchases
2026-11-10 15:38 · Yahoo
NeOnc Reports Third Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
2026-11-05 14:00 · Yahoo
NeOnc Technologies to Present Data from Its NEO100 and NEO212 Programs at the 31st Annual Meeting of the Society for Neuro-Oncology
2026-11-02 13:00 · Yahoo
NeOnc Technologies to Be Featured on Health Uncensored with Dr. Drew to Discuss Reaching Brain Tumors Without Surgery or Systemic Chemotherapy
2026-10-22 12:00 · Yahoo
NeOnc's Brain Cancer Efforts Bring Hope as FDA Meeting Approaches
2026-10-21 14:17 · Yahoo
NeOnc Technologies and the Department of Health – Abu Dhabi Sign MoU to Advance Brain Cancer Research and Proposed Clinical Collaboration
2026-10-21 12:00 · Yahoo
NeOnc's Most Challenging Test Yet: Compassionate-Use Update Puts NEO100's Potential in Focus
2026-10-16 13:27 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.